2Seventy Bio Inc(TSVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TSVT 2Seventy Bio Inc

盘前交易 11-20 08:43:21 EST

3.22

-0.14

-4.17%

最高3.41	最低3.20	成交量35.11万
今开3.41	昨收3.36	日振幅6.25%
总市值1.66亿	流通市值1.42亿	总股本5,159万
成交额114.69万	换手率0.80%	流通股本4,414万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TSVT","market":"US","secType":"STK","nameCN":"2Seventy Bio Inc","latestPrice":3.22,"timestamp":1732050000000,"preClose":3.36,"halted":0,"volume":351117,"delay":0,"floatShares":44135626,"shares":51588420,"eps":-1.818827,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.14,"latestTime":"11-20 08:43:21 EST","open":3.41,"high":3.41,"low":3.2,"amount":1146895.3804698,"amplitude":0.0625,"askPrice":3.57,"askSize":100,"bidPrice":3.03,"bidSize":900,"shortable":3,"etf":0,"ttmEps":-1.818827,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732113000000},"adr":0,"adjPreClose":3.22,"postHourTrading":{"tag":"盘后","latestPrice":3.22,"preClose":3.22,"latestTime":"16:49 EST","volume":1400,"amount":4507.94,"timestamp":1732052968114},"volumeRatio":1.0052939294202192,"impliedVol":1.3309,"impliedVolPercentile":0.4183},"requestUrl":"/m/hq/s/TSVT","defaultTab":"news","newsList":[{"id":"2484041136","title":"2Seventy Bio, Inc.盘中异动 股价大跌5.11%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484041136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484041136?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:02","pubTimestamp":1731952976,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时02分，2Seventy Bio, Inc.股票出现异动，股价大幅下挫5.11%。截至发稿，该股报3.34美元/股，成交量29.4809万股，换手率0.57%，振幅6.11%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119020256abcd06c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119020256abcd06c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSVT","BK4139"],"gpt_icon":0},{"id":"2483036373","title":"2Seventy Bio, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483036373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483036373?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:23","pubTimestamp":1731684223,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时23分，2Seventy Bio, Inc.股票出现波动，股价大幅下跌5.10%。截至发稿，该股报3.72美元/股，成交量7.802万股，换手率0.15%，振幅4.85%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体跌幅为3.16%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523234398e42fb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523234398e42fb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSVT","BK4139"],"gpt_icon":0},{"id":"2483334423","title":"2Seventy Bio, Inc.盘中异动 临近收盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483334423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483334423?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:36","pubTimestamp":1731616571,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时36分，2Seventy Bio, Inc.股票出现波动，股价大幅下挫5.08%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.79%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃，换手率分别为4898.10%、3457.51%、398.92%，振幅较大的相关个股有Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为249.67%、211.36%、188.46%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504361198e42ba1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504361198e42ba1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSVT"],"gpt_icon":0},{"id":"2482840082","title":"2Seventy Bio Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482840082","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482840082?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:35","pubTimestamp":1731425745,"startTime":"0","endTime":"0","summary":"   * 2Seventy Bio Inc   报告，截至9月30日的季度调整后每股亏损19美分，高于去年同期的每股收益1.00美元。六位分析师对该季度的平均预期是每股亏损 24 美分。华尔街预期为每股-35美分至-7美分。* 2Seventy Bio Inc公布的本季度每股收益为亏损19美分。* 该公司的季度亏损额为 993 万美元。* 2Seventy Bio Inc 本季度股价下跌了 2.5%，今年迄今为止上涨了 7.7%。华尔街对 2Seventy Bio Inc 的 12 个月目标价中位数为 8.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"2Seventy Bio Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TSVT"],"gpt_icon":0},{"id":"2482438144","title":"2Seventy Bio, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482438144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482438144?lang=zh_cn&edition=full","pubTime":"2024-11-09 01:30","pubTimestamp":1731087036,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日01时30分，2Seventy Bio, Inc.股票出现异动，股价快速下挫5.00%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.涨幅较大，Elevai Labs, Inc.、Lipella Pharmaceuticals Inc.、Matinas Biopharma Holdings, Inc.较为活跃，换手率分别为714.65%、67.89%、56.37%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为102.22%、87.00%、52.00%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109013036a2252ac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109013036a2252ac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSVT"],"gpt_icon":0},{"id":"2482248187","title":"2Seventy Bio Inc 预计每股亏损24美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482248187","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482248187?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:30","pubTimestamp":1731083410,"startTime":"0","endTime":"0","summary":"2Seventy Bio Inc 预计每股亏损24美分 - 财报前瞻2Seventy生物公司TSVT.OQ TSVT.O将于11月12日公布截至2024年9月30日的财报，预计该公司的季度收入将有所增长。LSEG 分析师对 2Seventy Bio Inc 的平均预期是每股亏损 24 美分。华尔街对 2Seventy Bio Inc 的 12 个月目标价中位数为 8.00 美元，高于其上次收盘价 5.01 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF22Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSVT"],"gpt_icon":0},{"id":"2481633160","title":"2Seventy Bio, Inc.盘中异动 急速拉升5.10%报4.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481633160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481633160?lang=zh_cn&edition=full","pubTime":"2024-11-06 01:15","pubTimestamp":1730826953,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日01时15分，2Seventy Bio, Inc.股票出现波动，股价急速上涨5.10%。截至发稿，该股报4.74美元/股，成交量10.6079万股，换手率0.21%，振幅5.76%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110601155398e409aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110601155398e409aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSVT","BK4139"],"gpt_icon":0},{"id":"2480066222","title":"2Seventy Bio, Inc.盘中异动 股价大跌5.02%报4.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480066222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480066222?lang=zh_cn&edition=full","pubTime":"2024-11-01 04:00","pubTimestamp":1730404818,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日04时00分，2Seventy Bio, Inc.股票出现异动，股价快速下跌5.02%。截至发稿，该股报4.35美元/股，成交量36.4976万股，换手率0.71%，振幅5.46%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体跌幅为3.04%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110104001898e3fcab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110104001898e3fcab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSVT","BK4139"],"gpt_icon":0},{"id":"2479236722","title":"2Seventy Bio, Inc.盘中异动 大幅下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479236722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479236722?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:39","pubTimestamp":1730219945,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时39分，2Seventy Bio, Inc.股票出现异动，股价大幅下跌5.02%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Dermata Therapeutics Inc C/Wts 涨幅较大，Lixte Biotechnology Holdings, Inc.、Glycomimetics, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为1326.81%、1168.31%、328.68%，振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Dermata Therapeutics Inc C/Wts ，振幅分别为183.65%、88.24%、78.31%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030003905a1f61cc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030003905a1f61cc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSVT","BK4139"],"gpt_icon":0},{"id":"2477520263","title":"2Seventy Bio, Inc.盘中异动 临近午盘股价大涨5.03%报5.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477520263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477520263?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:53","pubTimestamp":1729612383,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时53分，2Seventy Bio, Inc.股票出现异动，股价急速拉升5.03%。截至发稿，该股报5.22美元/股，成交量36.6597万股，换手率0.71%，振幅6.24%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022235304a1e2d599&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022235304a1e2d599&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSVT","BK4139"],"gpt_icon":0},{"id":"2472506595","title":"2Seventy Bio, Inc.盘中异动 临近收盘股价大涨5.00%报4.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472506595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472506595?lang=zh_cn&edition=full","pubTime":"2024-10-03 03:42","pubTimestamp":1727898155,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日03时42分，2Seventy Bio, Inc.股票出现波动，股价急速上涨5.00%。截至发稿，该股报4.83美元/股，成交量14.2519万股，换手率0.28%，振幅6.50%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003034236a1de0b2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003034236a1de0b2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSVT"],"gpt_icon":0},{"id":"2472337037","title":"2Seventy Bio, Inc.盘中异动 快速下跌5.48%报4.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472337037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472337037?lang=zh_cn&edition=full","pubTime":"2024-10-01 02:23","pubTimestamp":1727720581,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日02时23分，2Seventy Bio, Inc.股票出现波动，股价大幅下挫5.48%。截至发稿，该股报4.66美元/股，成交量7.7974万股，换手率0.15%，振幅8.31%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010223019719da5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010223019719da5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSVT","BK4139"],"gpt_icon":0},{"id":"2470412089","title":"2Seventy Bio, Inc.盘中异动 股价大跌5.88%报4.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470412089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470412089?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:43","pubTimestamp":1727444584,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时43分，2Seventy Bio, Inc.股票出现波动，股价快速下挫5.88%。截至发稿，该股报4.48美元/股，成交量6.5254万股，换手率0.13%，振幅7.35%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092721430498e3966d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092721430498e3966d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSVT","BK4139"],"gpt_icon":0},{"id":"2470857734","title":"2Seventy Bio, Inc.盘中异动 早盘股价大涨5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470857734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470857734?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:31","pubTimestamp":1727357514,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时31分，2Seventy Bio, Inc.股票出现波动，股价大幅拉升5.79%。截至发稿，该股报4.57美元/股，成交量1.5564万股，换手率0.03%，振幅1.39%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262131549719cd1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262131549719cd1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KTTA","TSVT"],"gpt_icon":0},{"id":"2470835291","title":"BUZZ--美国股票走势-SLM 公司、安进公司、Cintas 公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2470835291","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470835291?lang=zh_cn&edition=full","pubTime":"2024-09-26 02:24","pubTimestamp":1727288661,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月25日 - 华尔街主要股指周三涨跌不一，标普500指数在纪录高点附近徘徊，投资者在等待有关经济状况和即将到来的降息的更多指标。美东时间13:36，道琼斯工业平均指数  下跌0.7%，报41898.05点。标普500指数  下跌0.29%，报5716.13点；纳斯达克综合指数  下跌0.02%，报18070.558点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JEF","CVX","DPZ","DXD","EBS","FANG","PRGS","SFIX","BKSY","SLM","CTAS","HAL","UDOW","NOV","SLB","TSVT",".IXIC","AMGN","TSN","VTNR","RITM","QLD","APOG",".DJI","CIFR","BKR","HPE","XOM","FOXA","KBH","WVE","SQQQ","DOG","NQmain","DASH","L","SUI","GDDY","GM","QID","GPN"],"gpt_icon":1},{"id":"2470268899","title":"2Seventy Bio, Inc.盘中异动 股价大跌8.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470268899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470268899?lang=zh_cn&edition=full","pubTime":"2024-09-25 21:31","pubTimestamp":1727271109,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日21时31分，2Seventy Bio, Inc.股票出现波动，股价大幅下跌8.81%。截至发稿，该股报4.35美元/股，成交量4.3177万股，换手率0.08%，振幅3.98%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925213149957d078e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925213149957d078e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSVT","BK4139"],"gpt_icon":0},{"id":"2470522662","title":"BUZZ--美国股票走势-DoorDash、KB Home、泰森食品公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2470522662","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470522662?lang=zh_cn&edition=full","pubTime":"2024-09-25 21:19","pubTimestamp":1727270360,"startTime":"0","endTime":"0","summary":"** Schlumberger NV   ：盘前下跌0.3%BUZZ - Wells Fargo下调美国油田服务公司的PT值   ** 耐克公司  ：盘前下跌0.1%BUZZ--分析师称，耐克可能下调财年预测，因其在首席执行官变更后重新设定预期   ** Emergent BioSolutions Inc   ：盘前上涨 6.4%BUZZ - 因披露 2025 年前的 4 亿美元订单而上涨   ** 福特汽车公司  盘前下跌2.3** 通用汽车公司  ：盘前下跌 4.2%BUZZ - 摩根士丹利下调评级后股价下滑   ** Rivian Automotive Inc   ：盘前下跌4.0%BUZZ--摩根士丹利下调股票评级后股价下跌，下调PT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RITM","LU0329678170.USD","HPE","LU0143863784.USD","LU0329678337.USD","LU1923623000.USD","IE00B1BXHZ80.USD","NOV","IE000W1ABFV2.USD","PDD","LU0348723411.USD","BILI","JD","NIO","LU1951200564.SGD","SFIX","AAPL","LU0051755006.USD","IE0034235303.USD","DASH","ROKU","BABA","IE00BFSS8Q28.SGD","LU0052750758.USD","GM","LU0130102774.USD","LU1951198990.SGD","IE00BLSP4239.USD","LU0231483743.USD","NKE","LU0130518102.USD","KB","IE00BBT3K403.USD","BK4094","LU0823411888.USD","TSVT","BKR","SGXZ23171101.USD","IE00B3S45H60.SGD","BK4515","BK4516","LU0605514214.HKD","L","KBH","TSLA","BK4110","SLB","F","TSN","LU0130517989.USD","LU0251142724.SGD","EBS","BK4099","HAL"],"gpt_icon":1},{"id":"2470259399","title":"BUZZ-2seventy生物公司停止招收血癌治疗试验患者后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2470259399","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470259399?lang=zh_cn&edition=full","pubTime":"2024-09-25 20:19","pubTimestamp":1727266767,"startTime":"0","endTime":"0","summary":"    9月25日 - ** 癌症疗法制造商2seventy bio   股价盘前下跌9.8%至4.30美元** 该公司及其合作伙伴百时美施贵宝  将停止其细胞疗法在新诊断的多发性骨髓瘤患者中的晚期试验 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TSVT","BMY"],"gpt_icon":0},{"id":"2470599972","title":"2seventy bio(TSVT.US)与百时美施贵宝(BMY.US)停止多发性骨髓瘤疗法试验 预计节省8000万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470599972","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470599972?lang=zh_cn&edition=full","pubTime":"2024-09-25 20:16","pubTimestamp":1727266586,"startTime":"0","endTime":"0","summary":"据了解，2seventy bio和其合作伙伴百时美施贵宝宣布，将停止新诊断的多发性骨髓瘤患者使用的T细胞免疫疗法Abecma的III期临床试验。随着KarMMa-9新患者招募工作的停止，2seventy bio预计近期将节省8000多万美元的开支，这将有助于公司加快实现收支平衡的计划。在多发性骨髓瘤治疗市场上，2seventy bio和百时美施贵宝面临着来自传奇生物和强生公司联合开发的FDA批准的CAR-T细胞疗法Carvykti的直接竞争。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925202503957cea68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925202503957cea68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4581","LU2360032135.SGD","LU1571399168.USD","LU1261432733.SGD","LU1989771016.USD","LU0225284248.USD","LU1291159041.SGD","LU0237698245.USD","LU1718418525.SGD","LU0225771236.USD","LU1670711040.USD","BK4139","LU1585245621.USD","LU0456855351.SGD","LU2133065610.SGD","LU0321505439.SGD","IE00BJT1NW94.SGD","JNJ","LU1032466523.USD","BK4007","IE0009355771.USD","LU0306806265.USD","LU0985481810.HKD","LU1670711123.USD","BK4588","BK4532","BMY","LU0061475181.USD","LU0868494617.USD","LU1093756325.SGD","BK4559","BK4585","LU1074936037.SGD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","LU0114720955.EUR","LU1093756168.USD","LU1430594728.SGD","LU0882574055.USD","LU1670710661.SGD","LU0306807586.USD","LEGN","LU2125154778.USD","BK4534","LU1670710588.SGD","IE00B2B36J28.USD","TSVT","IE00BFTCPJ56.SGD","LU2242652126.USD","LU2242646821.SGD","LU2125154935.USD","IE0002141913.USD"],"gpt_icon":0},{"id":"2470231032","title":"2seventy生物公司停止招收血癌治疗研究患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2470231032","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470231032?lang=zh_cn&edition=full","pubTime":"2024-09-25 18:13","pubTimestamp":1727259201,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透9月25日 - 2seventy bio   周三表示，它将停止在其细胞疗法治疗新诊断骨髓瘤（一种血癌）的后期研究中招募新患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSVT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.2seventybio.com","stockEarnings":[{"period":"1week","weight":-0.2477},{"period":"1month","weight":-0.3547},{"period":"3month","weight":-0.3178},{"period":"6month","weight":-0.2682},{"period":"1year","weight":0.8506},{"period":"ytd","weight":-0.2459}],"compareEarnings":[{"period":"1week","weight":-0.0111},{"period":"1month","weight":0.0098},{"period":"3month","weight":0.0529},{"period":"6month","weight":0.1223},{"period":"1year","weight":0.2995},{"period":"ytd","weight":0.2419}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"2seventy bio, Inc.于2021年4月26日在特拉华州注册成立。该公司是一家细胞和基因治疗公司，专注于癌症转化疗法的研究、开发和商业化。该公司正在推进肿瘤学的多个临床前和临床项目，并与他们的合作伙伴百时美施贵宝(BMS)一起，在批准接受至少四种先前治疗的多发性骨髓瘤患者后，向美国的多发性骨髓瘤患者提供Abecma，包括免疫调节剂、蛋白酶体抑制剂和抗CD38单克隆抗体。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.127877},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.067186},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.021814},{"month":4,"riseRate":0,"avgChangeRate":-0.14211},{"month":5,"riseRate":0.333333,"avgChangeRate":0.033749},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.058538},{"month":7,"riseRate":0.666667,"avgChangeRate":0.022042},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.086933},{"month":9,"riseRate":0,"avgChangeRate":-0.095907},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.122217},{"month":11,"riseRate":0,"avgChangeRate":-0.260856},{"month":12,"riseRate":0.333333,"avgChangeRate":0.301445}],"exchange":"NASDAQ","name":"2Seventy Bio Inc","nameEN":"2Seventy Bio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"2Seventy Bio Inc(TSVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供2Seventy Bio Inc(TSVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"2Seventy Bio Inc,TSVT,2Seventy Bio Inc股票,2Seventy Bio Inc股票老虎,2Seventy Bio Inc股票老虎国际,2Seventy Bio Inc行情,2Seventy Bio Inc股票行情,2Seventy Bio Inc股价,2Seventy Bio Inc股市,2Seventy Bio Inc股票价格,2Seventy Bio Inc股票交易,2Seventy Bio Inc股票购买,2Seventy Bio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"2Seventy Bio Inc(TSVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供2Seventy Bio Inc(TSVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}